Need a mobile version?

ASCLS eNewsBytes
June. 22, 2010
ASCLS Quick Links >   Home    About    Scholarships    Meetings    Publications    Resources

The lab's role in diagnosis of neonatal hyperbilirubinemia
Clinical Laboratory News    Share   Share on FacebookTwitterShare on LinkedinE-mail article
Hyperbilirubinemia is one of the most common problems encountered in term newborns. Neonatal jaundice typically occurs as a part of normal newborn physiology three to five days after birth and is characterized by yellow-pigmented skin and increased bilirubin concentrations in blood. Normally, this final product of heme degradation binds to serum albumin, is transported to the liver where it is conjugated with glucuronic acid, and eventually gets secreted in bile. Due to the relative lack of glucuronyl transferase activity in the first days after birth, however, bilirubin concentrations increase in most newborns. More

FDA fines Red Cross $16 million after blood safety inspection
Los Angeles Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Food and Drug Administration fined the American Red Cross $16 million, alleging that the organization had been slipshod in the collection and manufacture of blood products. It was the latest in a string of multimillion-dollar penalties for failure to meet blood safety standards. More

New data on prognosis in minimally conscious and vegetative states
Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Results of two new studies provide valuable new information on the prognosis of minimally conscious and vegetative states. One report, by Jacques Luauté, MD, PhD, from the Rééducation Neurologique, Hôpital Henry Gabrielle, Saint Genis Laval, France, used data from a retrospective cohort study to examine long-term outcomes of MCS and VS patients up to five years after injury and found that in contrast to the VS patients, one-third of MCS patients improved more than a year after coma onset. More

Experimental flu treatment may help related virus
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
An experimental drug being developed to fight influenza may fight a common but little-known virus called parainfluenza virus, researchers and the company said. Tests in mice showed Fludase, made by privately held NexBio, could stop parainfluenza viruses from replicating, the researchers reported in the Journal of Infectious Diseases. Dr. Anne Moscona of Weill Cornell Medical Center in New York and colleagues tested varying doses of the drug, also known as DAS181, in lab dishes and on mice. More

Translating personalized medicine from concept to clinical tool
Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The commissioner of the U.S. Food and Drug Administration and the director of the National Institutes of Health have coauthored a new perspectives piece in the New England Journal of Medicine examining the reasons behind moves by the FDA to increase oversight of genetic testing. The article highlights the challenges in "moving from concept to clinical use" in the quest for personalized medicine. More


New lab coat technology may help prevent spread of bacteria
PR Newswire via The Sacramento Bee    Share    Share on FacebookTwitterShare on LinkedinE-mail article
According to the Centers for Disease Control and Prevention, 99,000 people die every year from infections acquired while in hospitals. "The goal in our profession is to help cure you not introduce you to another deadly infection," said Dr. Charles Kinder, Heart Rhythm expert and Director of Heart Rhythm Program at Heart Care Centers of Illinois. More

Stores pull Marie Callender's meals on salmonella fear
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Grocers Giant Food LLC and Stop & Shop Supermarket Co, said that they have removed all Marie Callender's Cheesy Chicken and Rice single-serve frozen entrees from their stores due to potential salmonella contamination. The announcements come a day after ConAgra Foods Inc, the product's maker, announced its own recall. ConAgra said it was informed by the U.S. Centers for Disease Control and Prevention of a possible association between the product and eight people in the United States who were infected with the salmonella bacteria. More

H1N1 flu vaccine may shield against 1918 strain
HealthDay News via Bloomberg BusinessWeek    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The H1N1 influenza vaccine distributed in 2009 also appears to protect against the 1918 Spanish influenza virus killed more than 50 million people nearly a century ago, new research in mice reveals. The finding stems from work funded by the U.S. National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, which examined the vaccine's efficacy in influenza protection among mice. More

Stem cells from own eyes restore vision to blind
Bloomberg BusinessWeek    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Patients blinded in one or both eyes by chemical burns regained their vision after healthy stem cells were extracted from their eyes and reimplanted, according to a report by Italian researchers at a scientific meeting. The tissue was drawn from the limbus, an area at the junction of the cornea and white part of the eye. It was grown on a fibrous tissue, then layered onto the damaged eyes. More

This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here.

Did someone forward this edition to you? Subscribe here - it's free!


James DeBois, Director of Advertising Sales

Download Media Kit

To contribute news to the ASCLS eNewsBytes, contact Yvette Craig, Senior Content Editor

Recent Issues

  • Dedicated - Helmer June 2010
  • June 15, 2010
  • June 8, 2010
  • June 1, 2010
  • Dedicated - Tosoh May 2010
  •  RSS Feed
    Most popular articles

    7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063